13F
中

CORT CORCEPT THERAPEUTICS INC

2026Q1 · CUSIP 218352102 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
348
Δ holders QoQ
-40
Breadth percentile
Top 96%
Whale holders
162
Δ whales
-5
Inst. holding value
$3.2B
New positions
70
Closed positions
110
Price momentum (1Q)
+39.1%
Put / Call
7/10

Breadth history (34 quarters)

2018Q1: Δ+24 · h=213 2018Q2: Δ+2 · h=215 2018Q3: Δ-10 · h=205 2018Q4: Δ+15 · h=220 2019Q1: Δ-12 · h=208 2019Q2: Δ-28 · h=180 2019Q3: Δ+12 · h=192 2019Q4: Δ+11 · h=203 2020Q1: Δ+1 · h=204 2020Q2: Δ+19 · h=223 2020Q3: Δ+1 · h=224 2020Q4: Δ+4 · h=228 2021Q1: Δ-18 · h=210 2021Q2: Δ-11 · h=199 2021Q3: Δ+1 · h=200 2021Q4: Δ+8 · h=208 2022Q1: Δ+19 · h=227 2022Q2: Δ-4 · h=223 2022Q3: Δ+18 · h=241 2022Q4: Δ+5 · h=246 2023Q1: Δ-13 · h=233 2023Q2: Δ-6 · h=227 2023Q3: Δ+20 · h=247 2023Q4: Δ+27 · h=274 2024Q1: Δ+12 · h=286 2024Q2: Δ+1 · h=287 2024Q3: Δ+34 · h=321 2024Q4: Δ+48 · h=369 2025Q1: Δ+53 · h=422 2025Q2: Δ+0 · h=422 2025Q3: Δ+8 · h=430 2025Q4: Δ-42 · h=388 2026Q1: Δ-40 · h=348 2018Q1: holders=213 2018Q2: holders=215 2018Q3: holders=205 2018Q4: holders=220 2019Q1: holders=208 2019Q2: holders=180 2019Q3: holders=192 2019Q4: holders=203 2020Q1: holders=204 2020Q2: holders=223 2020Q3: holders=224 2020Q4: holders=228 2021Q1: holders=210 2021Q2: holders=199 2021Q3: holders=200 2021Q4: holders=208 2022Q1: holders=227 2022Q2: holders=223 2022Q3: holders=241 2022Q4: holders=246 2023Q1: holders=233 2023Q2: holders=227 2023Q3: holders=247 2023Q4: holders=274 2024Q1: holders=286 2024Q2: holders=287 2024Q3: holders=321 2024Q4: holders=369 2025Q1: holders=422 2025Q2: holders=422 2025Q3: holders=430 2025Q4: holders=388 2026Q1: holders=348 -53 -26.5 +0 +26.5 +53 162307452 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 11 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 2% -6.2% +0.4%
2024Q4 Top 10% +3.1% -3.3%
2024Q3 Top 8% +20.8% +44.6%
2023Q4 Top 20% +23.7% +51.8%
2023Q3 Top 8% -10.1% +15.0%
2022Q3 Top 7% -14.7% -8.7%
2022Q1 Top 9% +38.2% +36.5%
2020Q2 Top 18% +30.1% +99.2%

Options Sentiment

Put holders
7
QoQ: -7
Call holders
10
QoQ: -6

See methodology →

Fundamentals

PE (TTM)
253.8
EPS (TTM)
$0.35
EPS YoY
-69.6%
Revenue (TTM)
$0.8B
Revenue YoY
+12.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $103M 2022-09-30: $102M 2022-12-31: $103M 2023-03-31: $106M 2023-06-30: $118M 2023-09-30: $124M 2023-12-31: $135M 2024-03-31: $147M 2024-06-30: $164M 2024-09-30: $183M 2024-12-31: $182M 2025-03-31: $157M 2025-06-30: $194M 2025-09-30: $208M 2025-12-31: $202M 2026-03-31: $165M 2022-06-30: EPS 0.24 2022-09-30: EPS 0.30 2022-12-31: EPS 0.13 2023-03-31: EPS 0.14 2023-06-30: EPS 0.25 2023-09-30: EPS 0.28 2023-12-31: EPS 0.27 2024-03-31: EPS 0.25 2024-06-30: EPS 0.32 2024-09-30: EPS 0.41 2024-12-31: EPS 0.25 2025-03-31: EPS 0.17 2025-06-30: EPS 0.29 2025-09-30: EPS 0.16 2025-12-31: EPS 0.20 2026-03-31: EPS -0.30 0M 104M 208M $M -0.33 0.06 0.45 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 42 2023-03-31: PE 30.22023-06-30: PE 37.32023-09-30: PE 31.42023-12-31: PE 24.22024-03-31: PE 26.82024-06-30: PE 30.32024-09-30: PE 41.52024-12-31: PE 59.12025-03-31: PE 65.32025-06-30: PE 64.12025-09-30: PE 86.82025-12-31: PE 48.72026-03-31: PE 161.1 22 95 169 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)